<p>FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation</p>-Reference-Cited by-同舟云学术

FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation

Published:2020-02 Issue: Volume:Volume 13 Page:1461-1470
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Ding Yudi,Qi Nana,Wang Ke,Huang Yiming,Liao Jinling,Wang Hongxue,Tan Aihua,Liu Lihua,Zhang Zhenqiang,Li Jinlong,Kong Jinliang,Qin Shouming,Jiang Yonghua^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference30 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Afatinib and chemotherapy in non-small-cell lung cancer

3. Nanomedicine for Treatment of Lung Cancer

4. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FTO promotes gefitinib-resistance by enhancing PELI3 expression and autophagy in non-small cell lung cancer;Pulmonary Pharmacology & Therapeutics;2024-12

2. FTO in Lung Cancer: Its Progression and Therapeutic Potential;Combinatorial Chemistry & High Throughput Screening;2024-09

3. N6-methyladenosine promotes aberrant redox homeostasis required for arsenic carcinogenesis by controlling the adaptation of key antioxidant enzymes;Journal of Hazardous Materials;2024-03

4. FTO-mediated autophagy inhibition promotes non-small cell lung cancer progression by reducing the stability of SESN2 mRNA;Heliyon;2024-03

5. METTL3 attenuates ferroptosis sensitivity in lung cancer via modulating TFRC;Open Medicine;2024-01-01